Ben Oakes, Scribe Therapeutics cofounder and CEO, discusses his journey in genome editing, transforming bacterial immune systems into genome editing tools. They explore the challenges of engineering these molecules and the potential for life-changing therapeutics. Topics include the intersection of engineering and biology, advancements in gene editing for chronic conditions, and the role of luck in discoveries.